More PI drug interactions.
D000730:Androstadienes / Q000009:adverse effects / Q000627:therapeutic use*; D019540:Area Under Curve; D004347:Drug Interactions; D004348:Drug Labeling; D005260:Female; D000068298:Fluticasone; D006207:Half-Life; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D018570:Risk Assessment; D019438:Ritonavir / Q000009:adverse effects / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000730:Androstadienes; D011480:Protease Inhibitors; D000068298:Fluticasone; D019438:Ritonavir